Skip to main content
OpenTrials
Completed

NCT Number: NCT03173768

Appropriateness of Intravenous Antibiotics Prescriptions at Hospital Discharge

A quasi-experimental study was conducted among patients receiving care at the medicine units of the Maharaj Nakorn Chiang Mai Hospital to determine the appropriateness of intravenous antibiotics at hospital discharge with and without ID consultation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

15 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Medicine

Chiang Mai, 50200, Thailand

About this study

The pre-intervention period was started from November 1, 2015 to April 30, 2016 (6-month period), in which the intravenous antibiotics at hospital discharge were prescribed by the primary care team. The post-intervention period was started from May 1, 2016 to February 28, 2017 (10-month period), in which the intravenous antibiotics at hospital discharge were reviewed and intervened by ID team.

The appropriateness of intravenous antibiotics was assessed separately by the ID fellow and ID specialist. If disagreement occurred, the feedback to the ID fellow was performed and the decision by ID specialist was used in the final analysis of appropriateness.

In post-intervention period, ID fellow modified the intravenous antibiotics ordered by the primary team if those intravenous antibiotics were judged as inappropriate by ID fellow as follows: 1) discontinue intravenous antibiotics (treatment was complete), 2) switch to oral antibiotics, 3) change intravenous antibiotics to cover isolated pathogens, 4) adjust the dose of intravenous antibiotics, and 5) change the duration of intravenous antibiotics

Finally, ID specialist retrospectively assessed the appropriateness of intravenous antibiotics at hospital discharge managed by ID fellow in post-intervention period.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All adult patients who met the following criteria were consecutively enrolled;

  • age≥ 15 years old and
  • had infections at any sites and received intravenous antibiotics.

Exclusion criteria

  • They were evaluated by infectious diseases specialist for appropriate antibiotics during admission

Treatment and study plan

ID specialist approval

Procedure

Appropriateness of intravenous antibiotics ordered by the primary team was assessed by ID specialist. ID fellow modified the intravenous antibiotics ordered by the primary team if those intravenous antibiotics were judged as inappropriate by ID fellow as follows: 1) discontinue intravenous antibiotics (treatment was complete), 2) switch to oral antibiotics, 3) change intravenous antibiotics to cover isolated pathogens, 4) adjust the dose of intravenous antibiotics, and 5) change the duration of intravenous antibiotics. Finally, ID specialist retrospectively assessed the appropriateness of intravenous antibiotics at hospital discharge managed by ID fellow in post-intervention period.

Primary outcomes

  1. The proportion of appropriateness of intravenous antibiotics prescriptions at hospital discharge between groups

    Time frame: 16 months

    To calculate the number of antibiotic prescriptions at hospital discharge over the total number of prescriptions, comparing between pre-and post-intervention period.

Secondary outcomes

  1. The costs of antibiotics for the course of treatment

    Time frame: 16 months

    To compare the cost of antibiotics for the course of treatment between the 2 periods

  2. Clinical improvement at 1 week

    Time frame: 1 week

    To calculate the number of patients who had clinical improvement at 1 week over the total number of patients in each period, comparing between the 2 periods

  3. Readmission within 30 days, length of hospital stay

    Time frame: 30 days

    To calculate the number of patients who were readmitted within 30 days over the total number of patients in each period, comparing between the 2 periods

  4. Length of hospital stay

    Time frame: 60 days

    To calculate the length of hospital stays in days between 2 periods

Sponsors and collaborators

Lead sponsor

Chiang Mai University

Other

Registry information

Official study title

Quasi-experimental Study Comparing Intravenous Antibiotics Prescriptions at Hospital Discharge With and Without ID Consultation

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Jun 2, 2017
Registry last updated
Jun 5, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.